ArticleImmunity, inflammation and disease2021

Predictors of breakthrough clinically significant cytomegalovirus infection during letermovir prophylaxis in high-risk hematopoietic cell transplant recipients.

Léna Royston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.